1.The response of CMI test following surgery, chemotherapy and immunotherapy in treatment of cancer patient.
Yeong Hwan KIM ; Seong Hwan KIM
Journal of the Korean Surgical Society 1993;44(3):334-342
No abstract available.
Drug Therapy*
;
Humans
;
Immunotherapy*
2.Secondary headache.
Journal of the Korean Academy of Family Medicine 1998;19(6):432-436
No abstract available.
Headache*
4.Alternative Medicine in U.S.A..
Journal of the Korean Medical Association 1998;41(12):1229-1232
No abstract available.
Complementary Therapies*
5.Motility Disorder of Biliary Tract.
Journal of the Korean Medical Association 1999;42(9):854-858
No abstract available.
Biliary Tract*
6.Bioequivalence Test and Its Significance.
Journal of the Korean Medical Association 2002;45(1):65-72
Bioequivalence is defined as the absence of a significant difference in the rate and extent to which the active ingredient or active moiety in pharmaceutical equivalents or pharmaceutical alternatives becomes available at the site of drug action when administered at the same molar dose under similar experimental conditions in either a single dose or multiple doses in an appropriately designed study. If a drug is to be bioequivalent to the reference drug, the confidence interval for both pharmacokinetic parameters, AUC(area under the plasma concentration-time curve) and Cmax(maximal plasma concentration), must be entirely within the 80% to 125% of those of the reference drug. Underlying the concept of bioequivalence is the thesis that, if a drug product contains a drug substance that is chemically identical and is delivered to the site of action at the same rate and extent as another drug product, then it is equivalent and can be substituted for that drug product. The primary concern from the regulatory point of view is the protection of the patient against approval of products that are not bioequivalent. In this paper the general concept and the practical significance of the bioequivalence is described. The recently revised Korean guideline for bioequivalence test is also discussed.
Drug Substitution
;
Humans
;
Molar
;
Plasma
;
Therapeutic Equivalency*
7.Diane in the Treatment of Female Acne: Interim Report of Multicenter Trial.
Korean Journal of Dermatology 1982;20(4):509-518
No abstract available.
Acne Vulgaris*
;
Female*
;
Humans
;
Multicenter Studies as Topic*
8.Sexually Transmitted Diseases and the Role of Dermatologists.
Korean Journal of Dermatology 1983;21(1):3-5
No abstract available.
Sexually Transmitted Diseases*
9.Medical Treatment of Intrahepatic Stones.
Korean Journal of Hepato-Biliary-Pancreatic Surgery 2008;12(1):17-23
No abstract available.
10.Headache in Children:Diagnosis and Treatment.
Journal of the Korean Pediatric Society 2003;46(Suppl 2):S241-S254
No abstract available.
Headache*